戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 1033478作成日:2026年10月25日

L-tert-Leucine → 3-Hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one, (2S,3S)-

https://huagongshe.com/reaction/1033478

反応式

関与物質

役割名称HCID仕込み量
反応物L-tert-LeucineHCID 164608—
反応物Sodium borohydrideHCID 4311764—
反応物1,5-Benzothiazepine-3,4(2H,5H)-dione, 2-(4-methoxyphenyl)-HCID 10902623—
溶媒TetrahydrofuranHCID 8028—
生成物3-Hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one, (2S,3S)-HCID 2733673—

反応条件

温度-15 °C

反応手順

A reducing agent is prepared in the same manner as in Example 9 from a mixture of L-tert-leucine (721 mg), sodium borohydride (189 mg) and tetrahydrofuran (50 ml), and the reaction mixture is cooled to -15° C. To the mixture is added 2-(4-methoxyphenyl)-1,5-benzothiazepine-3,4(2H,5H)-dione (997 mg), and the acid listed in the following Table 1 is added thereto at 30 minutes and 2 hours thereafter (totality: 3.33 mmole), and the reaction is carried out at the same temperature. After confirming by HPLC that the starting compound is completely consumed, the mixture is treated in the same manner as in Example 9 to give (2S,3S)-3-hydroxy-2-(4-methoxyphenyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one. The yield, optical purity of the cis-compound and content of the trans-compound are as shown in the following Table 1.

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US05310904
出典データセットuspto-grants-1994_05
ORD IDord-0fc81575510942588d1d5ba6fcd4de7b
出典メモuspto-grants-1994_05